PRLB Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 15.11%, SMA50 21.6%, SMA200 39.83%). The stock’s 14-day RSI is 72.14 (overbought), while the ATR of 2.59 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -3.03% below its high and over 125.86% above its low. Average 10-day trading volume of 271.19 thousand shares is significantly above the 3-month average of 163.81 thousand, indicating heightened recent market interest.

Proto Labs, Inc. has 23.87 million shares outstanding. The public float is 23.62 million shares, elevated short interest at 4.00% of float. This equals 667.97 thousand shares. The short ratio is 3.25 days. Institutional investors hold 93.57% of the float. Insiders own 1.35%. LUKIS LAWRENCE J holds 2.08 million shares, Bodor Robert has 80.88 thousand shares and HOLT VICTORIA M has 58.46 thousand shares. Over the past six months, insider transactions show net selling. They sold 5.55 thousand shares across 2 transactions.

Proto Labs, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $31.83. This means the shares are trading above this model’s fair value.

Proto Labs, Inc. (NYSE:PRLB) closed at $65.75 USD, losing -$1.07 (-1.60%) from the previous close of $66.82. The stock is currently within 5% of its 52-week high $29.59 and $68.91. With a market capitalization of about $1.56 billion, Proto Labs, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.28). Key stats such as the average daily volume over the past year has been around 175.22 thousand shares, in line with its 52-week average. Headquartered in Maple Plain, MN, Proto Labs, Inc. operates in the Industrials sector and the Manufacturing - Metal Fabrication industry. Led by CEO Suresh Krishna, the company employs approximately 2,357 people and listed since February 24, 2012. Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.

Proto Labs, Inc. generated EPS of $0.88 over the past year. Five-year average earnings growth is -14.26%. The latest quarter delivered EPS of $0.47. The next quarter is forecast at $0.40. Next year's EPS is expected at $6.35. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $55.00 to $51.00. The high target offers -16.35% upside. The low target suggests -22.43% downside. The mean target is $53.00. This offers -19.39% upside. Proto Labs, Inc. earnings surprise history is a mixed track record. The quarter that ended October 31, 2025, missed forecasts by 20.51%. The prior quarter beat by 24.24%. Over the last six quarters, Apple has recorded several small beats. These include -47.38% in August 02, 2024.

Proto Labs, Inc. trades at a P/E ratio of 73.38, slightly above the S&P 500 average, with a price-to-sales ratio of 2.91 and a price-to-book ratio of 2.32 suggesting the stock is closer to book value. The P/FCF stands at 23.9, also above market averages.

Proto Labs, Inc. (NYSE:PRLB) shares are flat 4.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Proto Labs, Inc. trading at a premium to the broader market with a P/E of 73.38. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $73.20, suggesting 11.33% upside. Our AI forecast model points to short-term strength (16.99% over two weeks), a medium-term rise (77.17% over three months), and a longer-term gain (11.56% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Proto Labs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 16.99%, with price expected at $76.92 by March 04, 2026, within a range of $73.54 to $80.39 3-Month Outlook: Projected rise of 77.17%, reaching $116.49 by May 19, 2026, with a range of $112.77 to $123.19. 1-Year Outlook: Projected gain of 11.56%, with price at $73.35 by February 18, 2027, within a range of $71.22 to $75.42.